Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Etiology-independent activation of the LTβ-LTβR-RELB axis drives aggressiveness and predicts poor prognosis in HCC.
Scherr AL, Nader L, Xu K, Elssner C, Ridder DA, Nichetti F, Mastel M, Fritzsche S, Kelmendi E, Schmitt N, Hoffmeister-Wittmann P, Weiler SME, Korell F, Albrecht T, Schwab M, Isele H, Kessler A, Hüllein J, Seretny A, Ye L, Urbanik T, Welte S, Leblond AL, Heilig CE, Rahbari M, Ali A, Gallage S, Lenoir B, Wilhelm N, Gärtner U, Ogrodnik SJ, Springfeld C, Tschaharganeh D, Fröhling S, Longerich T, Schulze-Bergkamen H, Jäger D, Brandl L, Schirmacher P, Straub BK, Weber A, De Toni EN, Goeppert B, Heikenwalder M, Jackstadt R, Roessler S, Breuhahn K, Köhler BC. Scherr AL, et al. Among authors: gallage s. Hepatology. 2023 Nov 2. doi: 10.1097/HEP.0000000000000657. Online ahead of print. Hepatology. 2023. PMID: 37916976
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer.
Revia S, Seretny A, Wendler L, Banito A, Eckert C, Breuer K, Mayakonda A, Lutsik P, Evert M, Ribback S, Gallage S, Chikh Bakri I, Breuhahn K, Schirmacher P, Heinrich S, Gaida MM, Heikenwälder M, Calvisi DF, Plass C, Lowe SW, Tschaharganeh DF. Revia S, et al. Among authors: gallage s. Gut. 2022 Aug;71(8):1613-1628. doi: 10.1136/gutjnl-2021-325405. Epub 2021 Sep 11. Gut. 2022. PMID: 34509979 Free PMC article.
Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASH.
Gallage S, Ali A, Barragan Avila JE, Herebian D, Karimi MM, Irvine EE, McHugh D, Schneider AT, Vucur M, Keitel V, Gil J, Withers DJ, Luedde T, Heikenwalder M. Gallage S, et al. Cell Mol Gastroenterol Hepatol. 2022;13(3):875-878. doi: 10.1016/j.jcmgh.2021.11.012. Epub 2021 Dec 6. Cell Mol Gastroenterol Hepatol. 2022. PMID: 34883280 Free PMC article. No abstract available.
Lethal lipotoxicity for liver cancer therapy.
Gallage S, Barragan Avila JE, Heikenwalder M. Gallage S, et al. Nat Cancer. 2021 Feb;2(2):138-140. doi: 10.1038/s43018-021-00175-y. Nat Cancer. 2021. PMID: 35122080 No abstract available.
Reply.
Gallage S, Ali A, Barragan Avila JE, Heikenwalder M. Gallage S, et al. Cell Mol Gastroenterol Hepatol. 2022;13(5):1590-1591. doi: 10.1016/j.jcmgh.2022.01.013. Epub 2022 Feb 12. Cell Mol Gastroenterol Hepatol. 2022. PMID: 35167819 Free PMC article. No abstract available.
The therapeutic landscape of hepatocellular carcinoma.
Gallage S, García-Beccaria M, Szydlowska M, Rahbari M, Mohr R, Tacke F, Heikenwalder M. Gallage S, et al. Med. 2021 May 14;2(5):505-552. doi: 10.1016/j.medj.2021.03.002. Epub 2021 Apr 27. Med. 2021. PMID: 35590232 Free article. Review.
A researcher's guide to preclinical mouse NASH models.
Gallage S, Avila JEB, Ramadori P, Focaccia E, Rahbari M, Ali A, Malek NP, Anstee QM, Heikenwalder M. Gallage S, et al. Nat Metab. 2022 Dec;4(12):1632-1649. doi: 10.1038/s42255-022-00700-y. Epub 2022 Dec 20. Nat Metab. 2022. PMID: 36539621 Review.
Intermittent fasting-the future treatment in NASH patients?
Minciuna I, Gallage S, Heikenwalder M, Zelber-Sagi S, Dufour JF. Minciuna I, et al. Among authors: gallage s. Hepatology. 2023 Oct 1;78(4):1290-1305. doi: 10.1097/HEP.0000000000000330. Epub 2023 Apr 17. Hepatology. 2023. PMID: 37057877 Review.
32 results